January 20, 2010
|
Lexicon shares up on good diabetes drug trial
Houston Business Journal Lexicon Pharmaceuticals Inc.’s share price soared Wednesday following news of a successful second trial for its diabetes treatment drug candidate. … Lexicon diabetes drug meets mid-stage trial goal Reuters Lexicon Pharma Gains On Study Results For Diabetes Treatment Wall Street Journal Promising diabetes data spur Lexicon shares FierceBiotech MarketWatch - World Market Media (blog) all 38 news articles » |
Filed under News and Info by on Jan 20th, 2010. Comment. 
December 31, 2009
 TopNews United States |
Biodel shares up on diabetes drug marketing application
Reuters O) shares rose as much as 27 percent Thursday, a day after the company filed for marketing approval for its experimental diabetes drug VIAject. … Biodel Seeks FDA Approval Of VIAject For Diabetes Treatment Wall Street Journal Biodel Submits Viaject New Diabetes Drug For FDA Approval Visit Bulgaria Biodel Submits VIAject New Drug Application To FDA For Treatment Of Diabetes … RTT News MSN Money - Earthtimes (press release) - StreetInsider.com (subscription) all 33 news articles » |
Filed under News and Info by on Dec 31st, 2009. Comment.
TopNews United States |
Biodel submits NDA for diabetes drug to FDA
Reuters O) said it submitted a new drug application to US health regulators for its experimental diabetes drug VIAject, sending its shares up 12 percent in … Biodel Seeks FDA Approval Of VIAject For Diabetes Treatment Wall Street Journal Biodel Submits VIAject New Drug Application To FDA For Treatment Of Diabetes … RTT News Biodel Submits VIAject® New Drug Application to FDA for Treatment of Diabetes Earthtimes (press release) MSN Money - TopNews United States - Pharmaceutical Business Review all 21 news articles » |
Filed under News and Info by on Dec 31st, 2009. Comment.
December 16, 2009
|
Amgen in Deal for Diabetes Drug
San Fernando Valley Business Journal Amgen Inc. entered into a $60 million deal for exclusive rights to a Type 2 diabetes drug from a Colorado biopharmaceutical company. … Array biopharma Rallies On Amgen Deal For Diabetes Treatment Wall Street Journal Amgen, Array biopharma enter development agreement BusinessWeek Amgen to develop Array diabetes drug Boulder County Business Report Genetic Engineering News (press release) - Zenopa - Daily Finance (blog) all 102 news articles » |
Filed under News and Info by on Dec 16th, 2009. Comment.
December 15, 2009
|
Amgen to develop Array diabetes drug
Boulder County Business Report BOULDER – Amgen Inc. will pay Array BioPharma Inc. $60 million up front to have exclusive worldwide rights to Array’s Type 2 diabetes drug … Array BioPharma Rallies On Amgen Deal For Diabetes Treatment Wall Street Journal Amgen, Array BioPharma enter development agreement Forbes Amgen Takes Over Array’s Type 2 Diabetes Program for $60M Up Front Genetic Engineering News (press release) PR Newswire (press release) - Motley Fool - Comtex Smartrend all 80 news articles » |
Filed under News and Info by on Dec 15th, 2009. Comment.